Long‐term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long‐term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension

Published:2022-01 Issue:1 Volume:12 Page:
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Tamura Yuichi¹²^ORCID,Furukawa Asuka¹²,Tamura Yudai²^ORCID,Yamada Kenta²,Taniguchi Hirohisa²,Fukuda Keiichi³,Kawamura Akio²,Satoh Toru⁴

Affiliation:

1. Pulmonary Hypertension Center International University of Health and Welfare Mita Hospital Tokyo Japan

2. Department of Cardiology International University of Health and Welfare School of Medicine Narita Japan

3. Department of Cardiology Keio University School of Medicine Tokyo Japan

4. Department of Cardiology Kyorin University School of Medicine Tokyo Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pul2.12058

Reference8 articles.

1. Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension

2. Risk stratification and medical therapy of pulmonary arterial hypertension

3. Transition from intravenous epoprostenol to selexipag in pulmonary arterial hypertension: a word of caution

4. Transitioning Between Prostanoid Therapies in Pulmonary Arterial Hypertension

5. Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment algorithm for pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

2. Hemodynamic assessment of transitioning from parenteral prostacyclin to selexipag in pediatric pulmonary hypertension;Pulmonary Circulation;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3